Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 5, 2007, Pages 492-497

  Kader, Adam S ^a   Lim, Jan T W ^a   Berthelet, Eric ^a   Petersen, Ross ^a   Ludgate, David ^a   Truong, Pauline T ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Anemia; Esophageal cancer; Prognosis; Survival; Transfusion

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS;

EID: 35148831214     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000264177.66369.18     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
2. Daly JM, Fry WA, Little AG, et al. Esophageal: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg. 2000;190:562-573.
3. Sobin LH, Wittekind Ch, eds. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss; 1997:57.
4. Earlam R, Cunha-Melo JR. Oesophogeal squamous cell carcinoma. II. A critical view of radiotherapy. Br J Surg. 1980;67:457-461.
5. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg. 1980;67:381-390.
6. Rades D, Schild SE, Bahrehmand R, et al. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels. Cancer. 2005;103:1740-1746.
7. Grogan M, Thomas GM, Melamed I, et al. The importance of haemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 1999;86:1528-1536.
8. Rudat V, Dietz A, Schramm O, et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol. 1999;53:119-125.
9. Becker A, Stadler P, Lavay RS, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2000;46:459-466.
10. Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment. Oncology. 2002;63(Suppl 2):11-18.
11. Ludwig H, Van Belle S, Barrett P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40:2293-2306.
12. Rades D, Tribius S, Yekebas EF, et al. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study. Int J Radiat Oncol Biol Phys. 2006;65:459-465.
13. Langendijka H, Jongb J, Wandersb R, et al. The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy. Radiother Oncol. 2003;67:321-325.
14. Rodgers GM III, Cella D, Chanan-Khan A, et al. Cancer- and treatment-related anemia. J Natl Compr Canc Netw. 2005;3:772-789.
15. Thomas GM. Raising hemoglobin: an opportunity for increasing survival? Oncology. 2002;63(Suppl 2):19-28.
16. Rizzo JD, Lichtin AE, Woolf SH, et al. American Society of Clinical Oncology and American Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20:4083-4107.
17. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
18. Harper P, Littlewood T. Anemia of cancer: impact on patient fatigue and long-term outcome. Oncology. 2005;69(Suppl 2):2-7.
19. Birgegård G, Aapro SA, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005;68(Suppl 1):3-11.